Late Breaking Abstract - Sodium/glucose co-transporter-2 inhibitors (SGLT2-i) in COPD and its effects on admission rates, length of stay and use of acute NIV. A Single-Centre 48-month retrospective observational study in a UK tertiary care centre. - Amsterdam 2025

Multifocal therapeutic strategies for airway diseases

Chair(s): Sachin Ananth, Rekha Chaudhuri

Session type: Poster session

Late Breaking Abstract - Sodium/glucose co-transporter-2 inhibitors (SGLT2-i) in COPD and its effects on admission rates, length of stay and use of acute NIV. A Single-Centre 48-month retrospective observational study in a UK tertiary care centre.

Alan Kan

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Multi-omics technologies characterize neutrophil-microbe interactions in non-cystic fibrosis bronchiectasis sputum

Theodore Kapellos

Poster

Abstract

Late Breaking Abstract - Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a 2-year RCT

Christine Jenkins

Poster

Abstract

Late Breaking Abstract - Human lung bronchial cells exposed to cigarette smoke: role of Adiponectin in Epithelial-Mesenchymal Transition

Francesca Panico

Poster

Abstract

Late Breaking Abstract - U-Shaped Association Between Blood Eosinophil Count and In-Hospital Mortality in Severe AECOPD

Abstract

Late Breaking Abstract - Dupilumab reduces the risk of severe exacerbations in patients with chronic obstructive pulmonary disease: results from BOREAS and NOTUS

Mona Bafadhel

Poster

Abstract

Late Breaking Abstract - Bispecific antibody targeting IL33 and TSLP for treating asthma and COPD

Zhenping Zhu

Poster

Abstract

Late Breaking Abstract - Bispecific antibody targeting IL13 and TSLP for treatment of respiratory diseases

Zhenping Zhu

Poster

Abstract

Late Breaking Abstract - Distinct effects of londamocitinib, AZD6793 and dexamethasone on gene expression in sputum macrophages from asthma and COPD

Zala Jevnikar Rojnik

Poster

Abstract

Late Breaking Abstract - Real-world evidence for severe Alpha-1 Antitrypsin Deficiency: Life-years gained for augmentation therapy versus standard care

Noel Gerard Mcelvaney

Poster

Abstract

Late Breaking Abstract - Vapendavir for the treatment of COPD patients challenged with rhinovirus: A phase 2a placebo-controlled study

Sebastian L. Johnston

Poster

Abstract

Late Breaking Abstract - Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids

Jonathan Noble

Poster

Abstract

Alan Kan

Poster

Abstract

Late Breaking Abstract - Reducing mast cells mitigates development of allergic asthma features

Yujiao Xiang

Poster

Abstract

Late Breaking Abstract - Immunoglobulin preparation trimodulin inhibits influenza infection in human viable lung tissue

Christina Hesse

Poster

Abstract

Late Breaking Abstract - A phase 2, dose-finding study of inhaled itraconazole in ABPA-complicating asthma

Ritesh Agarwal

Poster

Abstract

Late Breaking Abstract - Efficacy and Safety of TQC3403 in Patients with COPD: a Multicenter, Randomized, Open-label, Phase 3 Equivalence Trial

Dandan Chen

Poster

Abstract

Late Breaking Abstract - Sustained suppression of type 2 inflammatory biomarkers in asthma with APG808, a half-life extended anti-IL-4R? monoclonal antibody

Amol Kamboj

Poster

Abstract

Late Breaking Abstract - French claims database study in patients with severe asthma w/wo COPD using benralizuma: BENEFIT study

Gilles Devouassoux

Poster

Abstract

Late Breaking Abstract - Severe asthma biologic switches: an overview of outcomes at a UK regional centre

Galateia Verykokou

Poster

Abstract

Late Breaking Abstract - Bronchial Rheoplasty for Chronic Bronchitis: Results from the Randomized, Mechanical Sham-Controlled RheSolve Study

Arschang Valipour

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}